Overview

Genetic Variability in CYP2D6 in U.S Active Duty Population

Status:
Completed

Trial end date:
2017-08-01

Target enrollment:

Participant gender:

Summary

The investigator proposes to 2D6 (Cytochrome P-450 Isoenzyme 2D6) genotype and phenotype a group of active duty service members and assess the effects on primaquine metabolism.

Phase:

Phase 1

Details

Lead Sponsor:

Walter Reed Army Institute of Research (WRAIR)

Treatments:

Primaquine